Saturday, July 12, 2014





FDA panel opposes pure hydrocodone painkiller


February 19. 2013 9:03PM
Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


(AP) Government health experts overwhelmingly voted against a stronger version of hydrocodone, the powerful painkiller that is among the most widely abused medications in the U.S.


The Food and Drug Administration's panel of pain specialists voted 11-2 with one abstention against Zohydro for moderate to severe chronic pain. The drug was developed as a long-acting pain reliever by San Diego-based Zogenix Inc.


The FDA is not required to follow the group's recommendation, though it often does so.


If approved, Zohydro would be the first pure hydrocodone medication approved in the U.S. Existing products combine the drug with lower-strength painkillers such as acetaminophen.


Hydrocodone is prescribed to treat pain from injuries, surgery, arthritis, migraines and a variety of other ailments.


Associated Press


Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds